Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1990 1
1992 2
1993 2
1994 1
1995 1
1999 1
2000 1
2001 2
2002 2
2003 2
2005 1
2007 1
2010 1
2011 1
2012 3
2013 1
2014 3
2015 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Potent antimyeloma activity of a novel ERK5/CDK inhibitor.
Álvarez-Fernández S, Ortiz-Ruiz MJ, Parrott T, Zaknoen S, Ocio EM, San Miguel J, Burrows FJ, Esparís-Ogando A, Pandiella A. Álvarez-Fernández S, et al. Among authors: zaknoen s. Clin Cancer Res. 2013 May 15;19(10):2677-87. doi: 10.1158/1078-0432.CCR-12-2118. Epub 2013 Mar 26. Clin Cancer Res. 2013. PMID: 23532886
Aurora kinase A inhibitor, LY3295668 erbumine: a phase 1 monotherapy safety study in patients with locally advanced or metastatic solid tumors.
Chu QS, Bouganim N, Fortier C, Zaknoen S, Stille JR, Kremer JD, Yuen E, Hui YH, de la Peña A, Lithio A, Smith PS, Batist G. Chu QS, et al. Among authors: zaknoen s. Invest New Drugs. 2021 Aug;39(4):1001-1010. doi: 10.1007/s10637-020-01049-3. Epub 2021 Jan 22. Invest New Drugs. 2021. PMID: 33479856 Clinical Trial.
Therapeutic potential of ERK5 targeting in triple negative breast cancer.
Ortiz-Ruiz MJ, Álvarez-Fernández S, Parrott T, Zaknoen S, Burrows FJ, Ocaña A, Pandiella A, Esparís-Ogando A. Ortiz-Ruiz MJ, et al. Among authors: zaknoen s. Oncotarget. 2014 Nov 30;5(22):11308-18. doi: 10.18632/oncotarget.2324. Oncotarget. 2014. PMID: 25350956 Free PMC article.
Apricoxib upregulates 15-PGDH and PGT in tobacco-related epithelial malignancies.
St John MA, Wang G, Luo J, Dohadwala M, Hu D, Lin Y, Dennis M, Lee JM, Elashoff D, Lawhon T, Zaknoen SL, Burrows FJ, Dubinett SM. St John MA, et al. Among authors: zaknoen sl. Br J Cancer. 2012 Aug 7;107(4):707-12. doi: 10.1038/bjc.2012.203. Epub 2012 Jul 24. Br J Cancer. 2012. PMID: 22828609 Free PMC article.
The interleukin-2 receptor: a target for immunotherapy.
Waldmann TA, Goldman C, Top L, Grant A, Burton J, Bamford R, Roessler E, Horak I, Zaknoen S, Kasten-Sportes C, et al. Waldmann TA, et al. Among authors: zaknoen s. Adv Exp Med Biol. 1992;323:57-66. doi: 10.1007/978-1-4615-3396-2_8. Adv Exp Med Biol. 1992. PMID: 1485565 Review. No abstract available.
The interleukin-2 receptor: a target for immunotherapy.
Waldmann TA, Goldman C, Top L, Grant A, Burton J, Bamford R, Roessler E, Horak I, Zaknoen S, Kasten-Sportes C, et al. Waldmann TA, et al. Among authors: zaknoen s. Ann N Y Acad Sci. 1993 Jun 23;685:603-10. doi: 10.1111/j.1749-6632.1993.tb35923.x. Ann N Y Acad Sci. 1993. PMID: 8363269 Review. No abstract available.
27 results